MRAs can save resources for regulators and drug makers by, among other things, reducing the number of inspections and waiving retesting requirements.
The U.K. MHRA’s newly released framework offers long-awaited clarity by outlining when digital mental health technologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback